We are live on ! Find out more
TRDA icon

Entrada Therapeutics

55 hedge funds and large institutions have $411M invested in Entrada Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 14

6% more capital invested

Capital invested by funds: $390M → $411M (+$21.5M)

0.69% more ownership

Funds ownership: 77.57%78.26% (+0.69%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

2% less funds holding

Funds holding: 5655 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
55
Holders Change
-1
Holders Change %
-1.79%
% of All Funds
0.87%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
4
Increased
19
Reduced
14
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
$19.1K
TRCT
52
Tower Research Capital (TRC)
New York
$15.8K +$6.44K +409 +69%
Osaic Holdings
53
Osaic Holdings
Arizona
$4.74K
Citigroup
54
Citigroup
New York
$490 -$104K -6,632 -100%
Russell Investments Group
55
Russell Investments Group
United Kingdom
$142 -$106K -6,744 -100%
Millennium Management
56
Millennium Management
New York
-$277K -18,298 Closed
Man Group
57
Man Group
United Kingdom
-$219K -14,466 Closed
Marshall Wace
58
Marshall Wace
United Kingdom
-$171K -11,312 Closed
Lazard Asset Management
59
Lazard Asset Management
New York
-$36K -2,417 Closed
PNC Financial Services Group
60
PNC Financial Services Group
Pennsylvania
-$3.03K -200 Closed